Focused on H2-O2 medicine, Asclepius has conducted 300+ studies, 30 clinical trials (16 single/14 multi-center), published 90 papers, and secured 458 patents with China's top hospitals (to 2024).
As of December 1, 2024
Single Center Clinical Trials
Multi Center Clinical Trials